comparemela.com

Latest Breaking News On - Fierce pharma asia - Page 2 : comparemela.com

Fierce Pharma Asia—FDA oncology czar on China PD-1 rebuff; US Senate s supply chain bill; Insilico s AI targets

Richard Pazdur, M.D., director of the FDA's Oncology Center of Excellence, defended the agency's rejection of Eli Lilly and Innovent Biologics' PD-1 inhibitor. The U.S.

Richard pazdurPd 1 l1Supply chainFierce pharma asiaEli lillyInsilico medicineSfda inspectionOno pharmaceuticalImmuno oncologyHalozyme therapeuticsSubcutaneous drug deliveryAurobindo pharmaM amp aWerner baumannRare diseasesSun pharmaceutical

Fierce Pharma Asia—Chinese biotech s Pfizer trade secret suit; Lilly, Innovent s FDA rebuff; Aurobindo s New Jersey closure

The co-founders of a Chinese biotech have countersued their former employer Pfizer in a legal battle over alleged trade secret theft.

Fierce pharma asiaTrade secretsEli lillyComplete response letterPd 1 l1Aurobindo pharmaPlant closureSun pharmaceuticalM amp aFierce pharma homepage

Fierce Pharma Asia—Eisai s reduced Aduhelm role; Chinese biotechs US delisting risks; Zai Lab s new COO from Lilly

Eisai has decided to exit its supporting role for Biogen's Alzheimer's drug Aduhelm. Chinese companies including several biotechs face potential U.S.

Fierce pharma asiaSecurities and exchange commissionZai labEli lillyOmen 039s healthUltomiris ravulizumab cwvzPatent lawsuitsCovid 19Plant expansionDrug recallStevanato groupFierce pharma homepage

BeiGene, Hutchmed, Zai Lab tagged for potential US delisting under SEC audit rules, with more Chinese biotechs likely to face scrutiny

The U.S.

Securities and exchange commissionZai labSecurities lawFierce pharma asiaFierce pharma homepage

Fierce Pharma Asia—Legend CEO s cell therapy ambitions; Indian pharmas awkward position; new Hutchmed CEO

After its first commercial launch in Carvykti, Legend Biotech's CEO talked up the rising CAR-T star's cell therapy ambitions.

Fierce pharma asiaLegend biotechAr tCell therapyBiotech ceoCovid 19Vaccine developmentOmen 039s healthFierce pharma homepage

vimarsana © 2020. All Rights Reserved.